Arrowhead Pharmaceuticals, Inc announced earnings per share of $-0.12 and Sales of $0.73 millions in the forth quarter, Company's decreased loss per share, versus $-0.14 eps, earned in the same quarter a year ago, although Arrowhead Pharmaceuticals, Inc saw it's Sales rise by 29.16 % in the same period.

In the forth quarter company reported soft top and bottom-line results, where earnings per share plummeted by -48.46 % and revenue by -10.33 % year on year. Revenue were to $11.56 millions compare to $12.90 millions eps at $0.03 compare to $0.06 in same quarter a year ago.

Company displayed pleasant results in the third quarter. Sales were at $1.00 billions higher by 18.84 % year on year and increased by 4.03 % quarter on quarter, while earnings per share more than doubled by 300 % to $0.48, sequentially eps soared by 41.18 %.

Sales for the third quarter increased by 7.49 % to $174.11 millions in comparison to $161.98 millions in the prior year quarter, income increased by 7.14 % to $0.15 per share, as comparison at $0.14 in the prior year quarter.

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option.
Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071